Reports >
Life Sciences
>
Newborn Screening Market Report
Newborn Screening Market Size, Share, Industry Trends and Forecast to 2033
This report provides a comprehensive analysis of the Newborn Screening market, covering key insights and data from 2023 to 2033, including market size, growth projections, segmentation, and regional dynamics.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $4.50 Billion |
| CAGR (2023-2033) | 6.1% |
| 2033 Market Size | $8.26 Billion |
| Top Companies | PerkinElmer, Inc., Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Roche Diagnostics |
| Last Modified Date | 15 November 2024 |
Newborn Screening Market Report (2023 - 2033)
Newborn Screening Market Overview
What is the Market Size & CAGR of the Newborn Screening market in 2023?
Newborn Screening Industry Analysis
Newborn Screening Market Segmentation and Scope
Request a custom research report for industry.
Newborn Screening Market Analysis Report by Region
Europe Newborn Screening Market Report:
Europe is anticipated to grow significantly from $1.16 billion in 2023 to $2.12 billion by 2033 owing to stringent regulations promoting newborn health initiatives and increased healthcare expenditures.Asia Pacific Newborn Screening Market Report:
In the Asia Pacific region, the market is poised to grow significantly from $0.98 billion in 2023 to $1.79 billion in 2033. Factors driving growth include rising maternal and child health awareness and initiatives for early disease detection.North America Newborn Screening Market Report:
North America holds a substantial market share, projected to grow from $1.53 billion in 2023 to $2.81 billion in 2033, driven by advanced healthcare systems and high prevalence of congenital disorders.South America Newborn Screening Market Report:
South America is expected to see an increase from $0.23 billion in 2023 to $0.43 billion in 2033. The market is growing due to improved healthcare infrastructure and government-led screening programs.Middle East & Africa Newborn Screening Market Report:
The Middle East and Africa market is expected to grow from $0.60 billion in 2023 to $1.10 billion in 2033. This growth is attributed to increasing investments in health infrastructure and growing awareness regarding newborn screening.Request a custom research report for industry.
Newborn Screening Market Analysis By Test Type
Global Newborn Screening Market, By Test Type Market Analysis (2024 - 2033)
The Newborn Screening market, segmented by test type, includes key categories such as biochemical tests, genetic tests, and physiological tests. Biochemical tests dominate the market, accounting for $2.83 billion in 2023, with a growth forecast to $5.19 billion by 2033. Genetic tests and physiological tests are also significant, reflecting the industry's shift towards advanced testing methodologies.
Newborn Screening Market Analysis By Product
Global Newborn Screening Market, By Product Market Analysis (2024 - 2033)
Products used in newborn screening include reagents, testing equipment, and laboratory services. Reagents account for a substantial market share, expected to grow from $2.83 billion in 2023 to $5.19 billion in 2033, while testing equipment is projected to rise from $1.09 billion to $2.00 billion during the same period.
Newborn Screening Market Analysis By Technology
Global Newborn Screening Market, By Technology Market Analysis (2024 - 2033)
The technology segment of the Newborn Screening market is advancing rapidly, influenced by molecular diagnostics, immunoassays, chromatography, and other technologies. Molecular diagnostics currently leads with a projected increase from $2.83 billion in 2023 to $5.19 billion by 2033.
Newborn Screening Market Analysis By Application
Global Newborn Screening Market, By Application Market Analysis (2024 - 2033)
The primary applications within the Newborn Screening market encompass metabolic disorders, endocrine disorders, infectious diseases, and more. Metabolic disorders are the largest segment growing from $1.83 billion in 2023 to $3.35 billion in 2033, boosted by increased screening initiatives and awareness.
Newborn Screening Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Newborn Screening Industry
PerkinElmer, Inc.:
A global leader in newborn screening solutions, PerkinElmer provides a wide range of innovative tests and technologies to ensure the health and wellbeing of newborns.Abbott Laboratories:
Abbott is a major player in the healthcare industry, offering comprehensive newborn screening products that leverage advanced technology for effective screening.Thermo Fisher Scientific:
Thermo Fisher Scientific provides various diagnostics solutions for newborn screening, emphasizing innovation and high-quality testing.Agilent Technologies:
Agilent focuses on advanced instrumentations and technologies for genetic screening, enhancing the accuracy and efficiency of newborn health assessments.Roche Diagnostics:
Roche provides diagnostic solutions that aid in the early detection of various metabolic conditions, ensuring that newborns receive timely interventions.We're grateful to work with incredible clients.
